Yo-yo dieting has been criticised as previous research has shown it can increase the risk of a heart attack, stroke, diabetes, and higher blood pressure. But a major new study, published in the ...

Weight gain is a likely for anyone coming off weight-loss drugs – but it’s not inevitable. Here's what you can try to keep it ...

On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and ...

New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for ...

On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and with higher doses of WVE-007 (INHBE GalNAc-siRNA), while ...

South Korea Frozen Yogurt Market Size Set to Reach Healthy Value of USD 5.9 Billion by 2030 South Korea Frozen Yogurt Market is flourishing because of the increasing consumer awareness regarding ...

Helping our nation’s youth to become career ready requires greater access to meaningful opportunities and experiences that ignite their spark, help them find what excites them, and then plan education ...

Millions of Americans are turning to GLP-1 weight loss medications like Ozempic and Wegovy. But here’s the question few are ...

Working past unrealistic body standards allowed these celebs to focus on their health and happiness. From Kerry Washington to Elton John to Demi Lovato, even the biggest entertainers of our lifetime ...

Vivtex and Nimbus Therapeutics are working with big pharma to develop the next wave of oral obesity treatments. The post Two Boston startups join the race to create the next major weight-loss drug ...